Menu

EPA Stalls Release of Carcinogen Report

An investigation by Politico finds the agency has been sitting on an assessment of formaldehyde’s cancer risks for a year and a half.

Jul 9, 2018
Sukanya Charuchandra

ABOVE: The Environmental Protection Agency building in Washington, D.C.
ISTOCK, YINYANG

The Environmental Protection Agency is delaying the release of a draft assessment on formaldehyde that finds the chemical causes nasal and oral cancer and leukemia, according to Politico

The report has been ready since before President Donald Trump’s entry into the White House, yet it hasn’t been forwarded to the National Academies of Sciences for review nor been made public, reports Politico.

Politico’s investigation suggests that Environmental Protection Agency (EPA) officials have been suppressing the report to cater to the chemical industry. “At every corner, you see the agency trying to either minimize the role of science or manipulate the role of science or just ignore the work of scientists in doing the critical work to ensure that human health and the environment is protected,” Jennifer McPartland, a senior scientist with the Environmental Defense Fund, tells Politico. 

EPA denies the accusations. 

According to Vox, Democratic senators in a May letter to former EPA chief Scott Pruit say, “We have also learned that, at the same time as EPA political appointees’ requests were delaying the formaldehyde assessment’s movement through the agency review process, the American Chemistry Council (ACC) as well as interested corporation such as ExxonMobil have been pressuring EPA not to release the assessment for public comment as drafted.”

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.
Corning Introduces New 1536-well Spheroid Microplate
Corning Introduces New 1536-well Spheroid Microplate
High-throughput spheroid microplate benefits cancer research, drug screening